TY  - GEN
AU  - Mazières,Julien
AU  - Zalcman,Gérard
AU  - Crinò,Lucio
AU  - Biondani,Pamela
AU  - Barlesi,Fabrice
AU  - Filleron,Thomas
AU  - Dingemans,Anne-Marie C
AU  - Léna,Hervé
AU  - Monnet,Isabelle
AU  - Rothschild,Sacha I
AU  - Cappuzzo,Federico
AU  - Besse,Benjamin
AU  - Thiberville,Luc
AU  - Rouvière,Damien
AU  - Dziadziuszko,Rafal
AU  - Smit,Egbert F
AU  - Wolf,Jurgen
AU  - Spirig,Christian
AU  - Pecuchet,Nicolas
AU  - Leenders,Frauke
AU  - Heuckmann,Johannes M
AU  - Diebold,Joachim
AU  - Milia,Julie D
AU  - Thomas,Roman K
AU  - Gautschi,Oliver
TI  - Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort
SN  - 1527-7755
PY  - 2015///0528
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Crizotinib
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Europe
KW  - Female
KW  - Gene Rearrangement
KW  - Humans
KW  - Immunohistochemistry
KW  - In Situ Hybridization, Fluorescence
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Off-Label Use
KW  - Prospective Studies
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Protein-Tyrosine Kinases
KW  - genetics
KW  - Proto-Oncogene Proteins
KW  - Pyrazoles
KW  - Pyridines
KW  - Retrospective Studies
KW  - Translocation, Genetic
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2014.58.3302
ER  -